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Background: The sleep-disordered breathing, particularly central sleep apnea (CSA) is highly associated with heart failure. An apnea 
hypopnea index (AHI) and oxygen desaturation index (ODI), defined by the number of apnea and desaturation per hour of recording, 
respectively are diagnostic and prognostic tools for sleep-disordered breathing. We assessed the hypothesis that the severity of the oxygen 
desaturation rather than the AHI or ODI may have greater predictive power.
methods: We prospectively underwent an overnight cardiorespiratory polygraphy in 117 heart failure patients (age 70+/-1 years) before 
discharge from hospital between 2008 and 2011. We computed the duration of the >3%ODI during sleep and the area under the >3%ODI, 
in addition to the AHI and 3%ODI (Figure). We studied central sleep apnea and excluded obstructive sleep apnea. SDB values were 
transformed to natural logarithms.
results: During a mean follow-up period of 22 months, 23 patients (20%) had all-cause death. The duration of ln 3%ODI (hazard ratio: 
3.04, 95% confidence interval 1.46-6.34, p<0.01) and the area under the 3%ODI were independent predictors of mortality after adjusting for 
potential confounders (hazard ratio: 2.41, 95% confidence interval 1.25-4.66, p<0.01). The ln AHI was not an independent predictor of the 
mortality.
conclusion:  The duration of 3%ODI is a novel and useful prognostic marker in patients with heart failure and central sleep apnea.
